The Health Technology Expert Review Panel (HTERP) is an advisory body to CADTH, convened to develop guidance and/or recommendations on non-drug health technologies to inform a range of stakeholders within the Canadian health care system.
The HTERP approach is evidence-based and uses a multi-criteria framework that considers the strength and quality of available clinical evidence; the strength and quality of available economic information; current practices and resource utilization patterns; and other factors including, but not limited to, patient input and practical, ethical, environmental, and psychosocial considerations.
HTERP consists of six Core Members appointed to serve for all topics under consideration. In addition, specialists will be appointed on a per-project basis to provide subject matter expertise on specific topics. Core Members include individuals with qualifications in evidence-based medicine and/or critical appraisal, including a Chair, an ethicist, a health economist, a health care practitioner, and one Public Member who represents the broad public interest.
HTERP reports to the CADTH President and CEO. Committee members must abide by the Conflict of Interest Guidelines for Committee and Panel members and by the CADTH Code of Conduct. An honorarium is paid to the Health Technology Expert Review members for their preparation and meeting time.
Dr. Hilary Jaeger is a former Surgeon General of the Canadian Armed Forces and National Medical Officer of Veterans Affairs Canada. Starting out as a primary care physician, during her 30-year military career she served in many locations across Canada, and overseas in Germany, Croatia, Bosnia, and Afghanistan. Beyond hands-on care, she developed skills in health system leadership, development of health human resources, management of health-related research, and health policy development as she progressed to increasingly senior levels. Her principal professional interests at present concern the effect of health systems design and health policy decisions on population health outcomes.
Hilary serves as Vice-Chair of the Board of Directors of Osteoporosis Canada. She holds a Bachelor of Science in Mathematics from Acadia University; a Master of Science in Health Economics, Policy and Management from the London School of Economics; and a Doctor of Medicine from the University of Toronto.
Dr. Lawrence Mbuagbaw is a research methods scientist in clinical epidemiology and biostatistics. He trained at the Faculty of Medicine and Biomedical Sciences (FMBS) in Cameroon (MD, 2005), the Hebrew University of Jerusalem (MPH, 2009), and McMaster University (PhD in Health Research Methodology, 2014). He works as an assistant professor at McMaster University, where he teaches courses in biostatistics and randomized trials; and as a research methods scientist at the Research Institute of St Joseph’s Healthcare Hamilton (SJHH), where he provides methodological and statistical support for other researchers. This includes research questions formulation, study design, data analysis, and reporting. He is the principal investigator of numerous research projects covering a wide variety of research designs including randomized trials, mixed-methods studies, and qualitative studies. He has authored more than 140 peer-reviewed publications and technical reports for national and international institutions. His research interests are infectious diseases, mother and child health, mHealth, health systems strengthening, and the intersection of these fields.
Lawrence has served on various committees including the World Health Organization Guideline Development Group, working on HIV, malaria, and tuberculosis guidelines; G-I-N‒Guidelines International Network Africa and the Cochrane Africa network; the Ontario HIV Treatment Network Cohort Study; the ACCHO‒African and Caribbean Council on HIV/AIDS in Ontario; the Canadian Institutes of Health Research Canadian HIV Trials Network (CTN); and the Adherence Expert Review Panel of the Bill & Melinda Gates Foundation.
Dr. Jeremy Petch is the Managing Editor of Healthy Debate, the Manager of Special Projects at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, and an Assistant Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is also the co-creator of Faces of Health Care, which explores the human side of health policy through photography and storytelling. He sits on the Board of Directors of the Regent Park Community Health Centre and is the Chair of its Quality Committee.
Jeremy holds a PhD in Philosophy from York University, a graduate diploma from the Ontario Training Centre in Health Service and Policy Research, and Master’s and Bachelor’s (honours) degrees in Philosophy from the University of Victoria. His doctoral work focused on the intersection of ethics, law, and public policy in the regulation of genetic screening technologies. He was previously a Research Associate at the Institute for Work and Health.
Lynette Reid, PhD, is Associate Professor in the Department of Bioethics, Faculty of Medicine at Dalhousie University. In this capacity, she had collaborated with colleagues in leading the revision of the overall curriculum outcomes and the design and implementation of the two-year interdisciplinary Professional Competencies Unit.
Lynette’s research activities involve the interface of public health, health systems design, and medical practice. She is currently at work on a book project about ethical and philosophical issues in cancer screening and has recently edited a special issue concerning normative issues around “preferential access” in the Canadian health care system.
Tonya Somerton is an Acute Care Division Manager with Eastern Health in Newfoundland and Labrador. She graduated as a nurse in 2001 with a baccalaureate degree from Memorial University of Newfoundland (MUN). Tonya has practised in acute care settings her entire career and, while bedside nursing, focused mainly on critical/intensive and emergency care. She has been a Manager with Eastern Health since 2007, and in that role is responsible for all of the services under the Surgical Services and Children and Women’s Health programs at Carbonear General Hospital in Carbonear, NL. In 2015, Tonya completed a Masters in Technology Management at the Marine Institute of NL (MUN), during which her research focused on health technology assessment and prioritization of health technology acquisitions.
Trained as an economist (with a PhD in Economics from Concordia University in Montreal), Dr. Jean-Eric Tarride is an Associate Professor at McMaster University in the Department of Health Research Methods, Evidence, and Impact, and the Department of Economics. He is the Director of the Centre for Health Economics and Policy Analysis (CHEPA) at McMaster University and the co-Director of the Program for Assessment of Technology in Health (PATH), The Research Institute of St. Joe’s Hamilton, St. Joseph’s Healthcare Hamilton.
His primary research interests are in methods for the economic evaluation of health technologies and programs, and the treatment of uncertainty. Jean-Eric has authored more than 120 peer-reviewed journal articles related to economic evaluations of health care programs and has successfully collaborated with clinicians and academics by providing economic leadership in more than 70 peer-reviewed grants.
During his 10-plus years at PATH and McMaster University, Jean-Eric has designed and conducted pragmatic trials to inform the Ontario Health Technology Advisory Committee (OHTAC) and the Ontario Ministry of Health and Long-Term Care (MOHLTC) on the reimbursement and diffusion of medical technologies in Ontario. Jean-Eric received a five-year Career Scientist Award from the MOHLTC (2007-2011) for his contribution to health services research in Ontario. He is actively involved in graduate and professional education activities and teaches introductory to advanced courses in health technology management, as well as advanced decision-analytic modelling.
In addition to his academic expertise, Jean-Eric has worked for more than ten years in the pharmaceutical industry in various roles including Director of Health Economics and Reimbursement at AstraZeneca Canada (July 2012 to August 2014) and as Senior Manager of Outcomes Research at Pfizer Canada (2001 to 2005). He is currently a member of the CADTH pan-Canadian Oncology Drug Review (pCODR) Economic Guidance Panel.
Dr. Sandor Demeter received his BSc (1986) and MD (1989) from the University of Saskatchewan; his Canadian Royal College Fellowship (FRCPC) in Community Medicine and Public Health (1994), and a Master of Health Science in Community Health and Epidemiology (1993), from the University of Toronto; his FRCPC in Nuclear Medicine (2002) and an MSc (2004) from the University of Alberta; and most recently his Master of Science in Health Physics (2016) from the Illinois Institute of Technology in Chicago. Sandor’s career includes a decade working in public health and more than a decade in clinical nuclear medicine. He has held a number of senior medical and academic administrative positions, and is currently a staff physician with the section of nuclear medicine at Health Sciences Centre in Winnipeg. Sandor is also an Associate Professor at the University of Manitoba College of Medicine and an adjunct appointment in the Department of Physics at the University of Winnipeg. He is a Commission member with the Canadian Nuclear Safety Commission (CNSC), as well as a committee member with the ICRP‒International Commission on Radiological Protection. Sandor’s main research interests include the public health aspects of ionizing radiation and health technology assessment and health economics policy.